Home   Drug Development   CRO Services   Newsroom   About ReceptoPharm   Contact
» Recent News
» Archives
» E-Alerts
 
Drug Development

ReceptoPharm is developing proprietary therapeutic protein products for the treatment of neurological, viral and and autoimmune disorders.

» Learn More
 
CRO Services

ReceptoPharm offers a full range of contract research services catering to small and start-up biotech companies.

» Learn More

Archives

Please select a year from the tabs below to begin viewing archived ReceptoPharm press releases. For a complete listing of Nutra Pharma press releases, please click here.

2016

2015

2014

2013

2012

2011

2010

November 05, 2010
Nutra Pharma Awarded Grant under the Qualifying Therapeutic Discovery Project Program
October 26, 2010
Nutra Pharma Selects Nutritional Alliance as its Global Sales Agent
September 27, 2010
Nutra Pharma Introduces Nyloxin for Pets - a Treatment for Moderate to Severe Chronic Pain in Companion Animals
September 14, 2010
Nutra Pharma Amends Cobroxin Distribution Agreement with XenaCare Holdings
August 19, 2010
Nutra Pharma Begins Drug Registration Process in India for Nyloxin - a Treatment for Moderate to Severe Chronic Pain
August 09, 2010
Nutra Pharma Announces Amarey Nova Medical as its Exclusive Nyloxin Distributor in Colombia
August 06, 2010
Nutra Pharma Announces Second Quarter 2010 Sales and Distribution Update
July 28, 2010
Nutra Pharma Receives Patent for Novel Antiviral Treatment using Modified Cobra Venom
July 22, 2010
Nutra Pharma Drug Discovery Subsidiary to Introduce Novel Antiviral Therapy at the International AIDS Conference in Vienna, Austria
June 23, 2010
Nutra Pharma Begins Drug Registration Process in Central America for its Nyloxin Pain Reliever
June 10, 2010
Nutra Pharma Announces Grupo Farmaceutico de Tijuana as its Exclusive Nyloxin Distributor in Mexico
June 01, 2010
Nutra Pharma Partners with Henry Schein for Distribution of Nyloxin-Branded Pain Relievers
May 25, 2010
Nutra Pharma Announces First Manufacturing Release of Nyloxin Rx, a Prescription Treatment for Chronic Pain
March 30, 2010
Over-the-Counter Pain Reliever, Cobroxin, Now Available in CVS
March 25, 2010
Nutra Pharma to Present and Exhibit at Upcoming Investment Conferences in Vancouver, Canada, and Las Vegas, Nevada
February 02, 2010
Nutra Pharma Announces Fourth Quarter Sales for its Over-the-Counter (OTC) Pain Reliever, Cobroxin

2009

December 07, 2009
Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx - Over-the-Counter and Prescription Treatments for Chronic Pain
December 03, 2009
Nutra Pharma Announces Upcoming Webinar to Discuss the Company's Over-the-Counter (OTC) and Prescription Treatments for Chronic Pain
November 19, 2009
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution
October 14, 2009
Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain
October 07, 2009
Nutra Pharma Announces Nyloxin Rx, a Prescription Analgesic for the Treatment of Severe (Stage 3) Chronic Pain
October 02, 2009
Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain
September 21, 2009
Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever
August 31, 2009
Nutra Pharma's Recently Launched Pain Reliever, Cobroxin, Wins "Best New Product" Award at Retailing Conference
August 26, 2009
Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain
August 24, 2009
Nutra Pharma Completes FDA Submission for Cobroxin - a Drug for the Treatment of Stage 2 (Moderate to Severe) Chronic Pain
August 20, 2009
Nutra Pharma Announces Launch of Cobroxin, an Over-The-Counter (OTC) Treatment for Stage 2 (Moderate to Severe) Chronic Pain
August 13, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for the Oral Delivery of Cobra Venom for the Treatment of Pain
June 08, 2009
Nutra Pharma Announces Study Showing RPI-78 More Effective than Morphine in the Treatment of Moderate to Severe Pain
March 26, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Introduces Cost Effective Contract Research Services for Early Stage Life Science Firms
March 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Announces Achievement of ISO Class 5 Cleanroom Certification
February 17, 2009
Nutra Pharma Announces Publication of Positive Results of ReceptoPharm Arthritis Study
February 09, 2009
Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application for Novel Treatment of Arthritis Using RPI-78
Recent News
November 05, 2010
Nutra Pharma Awarded Grant under the Qualifying Therapeutic Discovery Project Program
 
E-Alerts
Signup to receive news and announcements from ReceptoPharm and Nutra Pharma:
First Name:
Last Name:
Email:
NPC